MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the

Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the

Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving

Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent

Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved

Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the

MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of